Natixis Advisors
STJ

Natixis Advisors’s St Jude Medical STJ Stock Holding History

Natixis Advisors’s Portfolio STJ Stock Details STJ Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2017
Q1 		– Sell
-10,908
Closed -$875K – 1076
2016
Q4 		$875K Sell
10,908
-1,094
-9% -$86.8K 0.01% 860
2016
Q3 		$957K Sell
12,002
-5,481
-31% -$442K 0.01% 816
2016
Q2 		$1.36M Sell
17,483
-1,599
-8% -$114K 0.02% 722
2016
Q1 		$1.05M Buy
19,082
+3,392
+22% +$185K 0.02% 790
2015
Q4 		$969K Sell
15,690
-7,266
-32% -$458K 0.02% 775
2015
Q3 		$1.45M Buy
22,956
+6,853
+43% +$489K 0.03% 688
2015
Q2 		$1.18M Sell
16,103
-24,942
-61% -$1.8M 0.02% 748
2015
Q1 		$2.68M Sell
41,045
-30,832
-43% -$2.05M 0.05% 550
2014
Q4 		$4.67M Buy
71,877
+44,407
+162% +$2.86M 0.09% 355
2014
Q3 		$1.65M Sell
27,470
-17,424
-39% -$1.14M 0.03% 643
2014
Q2 		$3.11M Buy
44,894
+18,026
+67% +$1.17M 0.04% 565
2014
Q1 		$1.76M Sell
26,868
-7,486
-22% -$487K 0.03% 646
2013
Q4 		$2.13M Sell
34,354
-8,999
-21% -$521K 0.03% 581
2013
Q3 		$2.33M Buy
43,353
+8,083
+23% +$416K 0.04% 546
2013
Q2 		$1.61M Buy
+35,270
New +$1.53M 0.03% 584

Other funds holding STJ

FPF
FNY Partners Fund New York $185M AUM 32.57% 1-Year Est. Return
JWA
JFS Wealth Advisors Hermitage, Pennsylvania $2.01B AUM 21.74% 1-Year Est. Return
Envestnet Asset Management
Envestnet Asset Management Chicago, Illinois $374B AUM 17.66% 1-Year Est. Return
AIM
Advantage Investment Management Cedar Rapids, Iowa $128M AUM 0.94% 1-Year Est. Return

Natixis Advisors's STJ Position: Q1 2017 in Review

Natixis Advisors sold out of St Jude Medical (STJ) in Q1 2017, closing a stake of 10,908 shares — an estimated $875K sold.

Natixis Advisors first reported a position in STJ in Q2 2013 and held it in 15 quarters. The position peaked at $4.67M in Q4 2014. 4 funds tracked by Wall St. Rank hold STJ as of Q1 2017.

  • Natixis Advisors reported no remaining St Jude Medical position as of Q1 2017 after selling out during the quarter.
  • Natixis Advisors sold 10,908 St Jude Medical shares in Q1 2017, an estimated $875K.
  • Natixis Advisors first reported a position in St Jude Medical in Q2 2013 and held it in 15 quarters.
  • Natixis Advisors's St Jude Medical position peaked at $4.67M in Q4 2014.
  • 4 funds tracked by Wall St. Rank held St Jude Medical as of Q1 2017.

Based on Natixis Advisors's 13F filing for Q1 2017, filed 12 May 2017.